MetLife Investment Management’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding BCEL
BBA
RG
EC
BC
GF
MetLife Investment Management's BCEL Position: Q2 2021 in Review
MetLife Investment Management sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q2 2021, closing a stake of 4,630 shares — an estimated $71K sold.
MetLife Investment Management first reported a position in BCEL in Q1 2020 and held it in 5 quarters. The position peaked at $262K in Q2 2020. 108 funds tracked by Wall St. Rank hold BCEL as of Q2 2021.
- MetLife Investment Management reported no remaining Atreca, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
- MetLife Investment Management sold 4,630 Atreca, Inc. Class A Common Stock shares in Q2 2021, an estimated $71K.
- MetLife Investment Management first reported a position in Atreca, Inc. Class A Common Stock in Q1 2020 and held it in 5 quarters.
- MetLife Investment Management's Atreca, Inc. Class A Common Stock position peaked at $262K in Q2 2020.
- 108 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q2 2021.
Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.